Area of research
Oncology · Cellular and Molecular Neuroscience
Research interest
Research interests include Medicine, Oncology, Lung cancer, Apatinib, Internal medicine, and Chemotherapy.
Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
Systematic profiling of Taxol resistance and sensitivity to tubulin missence mutations at molecular and cellular levels
Discovery and Engineering of a Novel Peptide, Temporin-WY2, from Frog Skin Secretion, With Enhanced In Vitro and In Vivo Antimicrobial Efficacy against Multi-drug Resistant Bacteria
Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC